Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: A systematic review and meta-analysis

10.1186/s12882-016-0368-6

Saved in:

Bibliographic Details
Main Authors:	Tan, J, Liu, S, Segal, J.B, Alexander, G.C, McAdams-Demarco, M
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Review
Published:	2020
Subjects:	acetylsalicylic acid apixaban dabigatran placebo rivaroxaban warfarin anticoagulant agent atrial fibrillation bleeding brain ischemia cerebrovascular accident cohort analysis disease association drug use end stage renal disease evidence based medicine gastrointestinal hemorrhage human meta analysis mortality observational study quantitative analysis randomized controlled trial (topic) Review risk assessment risk benefit analysis systematic review thrombosis treatment response complication hemodialysis Hemorrhage Kidney Failure, Chronic Stroke Anticoagulants Atrial Fibrillation Humans Renal Dialysis Warfarin
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/181332
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-181332
record_format	dspace
spelling	sg-nus-scholar.10635-1813322024-11-11T11:08:16Z Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: A systematic review and meta-analysis Tan, J Liu, S Segal, J.B Alexander, G.C McAdams-Demarco, M DUKE-NUS MEDICAL SCHOOL acetylsalicylic acid apixaban dabigatran placebo rivaroxaban warfarin anticoagulant agent warfarin atrial fibrillation bleeding brain ischemia cerebrovascular accident cohort analysis disease association drug use end stage renal disease evidence based medicine gastrointestinal hemorrhage human meta analysis mortality observational study quantitative analysis randomized controlled trial (topic) Review risk assessment risk benefit analysis systematic review thrombosis treatment response atrial fibrillation complication hemodialysis Hemorrhage Kidney Failure, Chronic mortality Stroke Anticoagulants Atrial Fibrillation Hemorrhage Humans Kidney Failure, Chronic Renal Dialysis Stroke Warfarin 10.1186/s12882-016-0368-6 BMC Nephrology 17 1 157 2020-10-27T10:36:08Z 2020-10-27T10:36:08Z 2016 Review Tan, J, Liu, S, Segal, J.B, Alexander, G.C, McAdams-Demarco, M (2016). Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: A systematic review and meta-analysis. BMC Nephrology 17 (1) : 157. ScholarBank@NUS Repository. https://doi.org/10.1186/s12882-016-0368-6 14712369 https://scholarbank.nus.edu.sg/handle/10635/181332 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	acetylsalicylic acid apixaban dabigatran placebo rivaroxaban warfarin anticoagulant agent warfarin atrial fibrillation bleeding brain ischemia cerebrovascular accident cohort analysis disease association drug use end stage renal disease evidence based medicine gastrointestinal hemorrhage human meta analysis mortality observational study quantitative analysis randomized controlled trial (topic) Review risk assessment risk benefit analysis systematic review thrombosis treatment response atrial fibrillation complication hemodialysis Hemorrhage Kidney Failure, Chronic mortality Stroke Anticoagulants Atrial Fibrillation Hemorrhage Humans Kidney Failure, Chronic Renal Dialysis Stroke Warfarin
spellingShingle	acetylsalicylic acid apixaban dabigatran placebo rivaroxaban warfarin anticoagulant agent warfarin atrial fibrillation bleeding brain ischemia cerebrovascular accident cohort analysis disease association drug use end stage renal disease evidence based medicine gastrointestinal hemorrhage human meta analysis mortality observational study quantitative analysis randomized controlled trial (topic) Review risk assessment risk benefit analysis systematic review thrombosis treatment response atrial fibrillation complication hemodialysis Hemorrhage Kidney Failure, Chronic mortality Stroke Anticoagulants Atrial Fibrillation Hemorrhage Humans Kidney Failure, Chronic Renal Dialysis Stroke Warfarin Tan, J Liu, S Segal, J.B Alexander, G.C McAdams-Demarco, M Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: A systematic review and meta-analysis
description	10.1186/s12882-016-0368-6
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Tan, J Liu, S Segal, J.B Alexander, G.C McAdams-Demarco, M
format	Review
author	Tan, J Liu, S Segal, J.B Alexander, G.C McAdams-Demarco, M
author_sort	Tan, J
title	Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: A systematic review and meta-analysis
title_short	Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: A systematic review and meta-analysis
title_full	Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: A systematic review and meta-analysis
title_fullStr	Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: A systematic review and meta-analysis
title_full_unstemmed	Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: A systematic review and meta-analysis
title_sort	warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/181332
_version_	1821186308162191360

Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: A systematic review and meta-analysis

Similar Items